Fludarabine phosphate

Suppliers

Names

[ CAS No. ]:
75607-67-9

[ Name ]:
Fludarabine phosphate

[Synonym ]:
2-Fluoro-9-(5-O-phosphono-β-D-arabinofuranosyl)-9H-purin-6-amine
2-fluoro-araamp
Fludara
Fludarabin Phosphate
Fludarabine (phosphate)
2-fluoro-ara-C-5'-O-phosphate
2-Fluoroadenine arabinoside 5'-monophosphate
fludarabinemonophosphate
Fludarabine 5'-Phosphate
fludarabine hcl
fludarabine monophosphate
Fludura
Fludarabine Phosphate (Fludara)
Fludarabine 5'-monophosphate
Fludarabine phosphate
fludarabine
9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-β-D-arabinofuranosyl)-
FLUDARUBINE PHOSPHATE
[(2R,3S,4S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen phosphate
F-ara-AMP
FAMP
MFCD00866418

Chemical & Physical Properties

[ Density]:
2.4±0.1 g/cm3

[ Boiling Point ]:
864.2±75.0 °C at 760 mmHg

[ Melting Point ]:
203 °C(dec.)

[ Molecular Formula ]:
C10H13FN5O7P

[ Molecular Weight ]:
365.212

[ Flash Point ]:
476.4±37.1 °C

[ Exact Mass ]:
365.053650

[ PSA ]:
195.88000

[ LogP ]:
0.41

[ Vapour Pressure ]:
0.0±0.3 mmHg at 25°C

[ Index of Refraction ]:
1.879

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UO7440900
CHEMICAL NAME :
9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)-
CAS REGISTRY NUMBER :
75607-67-9
LAST UPDATED :
198910
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C10-H13-F-N5-O7-P
MOLECULAR WEIGHT :
365.25

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - child
DOSE/DURATION :
18750 mg/kg/5D-I
TOXIC EFFECTS :
Brain and Coverings - encephalitis Sense Organs and Special Senses (Eye) - visual field changes
REFERENCE :
CTRRDO Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 70,1225,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
17760 mg/kg/5D-I
TOXIC EFFECTS :
Brain and Coverings - demyelination Behavioral - hallucinations, distorted perceptions Behavioral - coma
REFERENCE :
CTRRDO Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 70,1225,1986
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
14245 mg/kg/5D
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - excitement Skin and Appendages - sweating
REFERENCE :
CTRRDO Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 70,1449,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
23125 mg/kg/5D-I
TOXIC EFFECTS :
Brain and Coverings - encephalitis Sense Organs and Special Senses (Eye) - visual field changes Behavioral - somnolence (general depressed activity)
REFERENCE :
CTRRDO Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 70,1225,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
11655 mg/kg/5D-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - visual field changes Sense Organs and Special Senses (Eye) - ptosis Behavioral - somnolence (general depressed activity)
REFERENCE :
CTRRDO Cancer Treatment Reports. (Washington, DC) V.60-71, 1976-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 70,1449,1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1236 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: PB83-195685

Safety Information

[ Hazard Codes ]:
T

[ Risk Phrases ]:
R25:Toxic if swallowed.

[ Safety Phrases ]:
S45

[ RIDADR ]:
UN 2811 6.1/PG 3

[ HS Code ]:
2934999090

Synthetic Route

Precursor & DownStream

Precursor

  • 2-Fluoroadenosine
  • Trimethyl phosphate

DownStream

  • 2-Fluoroadenosine

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.

Cancer Chemother. Pharmacol. 75(1) , 67-75, (2015)

Quantitative relationships between 9-β-D-arabinofuranosyl-2-fluoroadenine (F-ara-A) concentrations and lymphosuppression have not been reported, but would be useful for regimen design. A population ph...

Fludarabine phosphate in lymphoma: an important new therapeutic agent.

Cancer Treat. Res. 85 , 3-14, (1996)

Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.

Cancer Treat. Res. 64 , 105-19, (1993)


More Articles


Related Compounds

  • Fludarabine Phosphate iMpurity B
  • Fludarabine triphosphate
  • Fludarabine-Cl
  • Adenine, 9-a-D-arabinofuranosyl-2-fluoro-(8CI)
  • Fludarabine
  • Piperaquine phosphate